In December 2021, Roche announced the acquisition of a trusted long-term partner, TIB Molbiol, based in Berlin, Germany.
TIB Molbiol expands and complements Roche Diagnostics’ molecular offerings with an additional >200 Life Science Research (LSR) assays covering a wide range of infectious disease pathogens and genetic targets.